Angiotensin II at1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Igase, Michiya ^a   Strawn, William B ^a   Gallagher, Patricia E ^a   Geary, Randolph L ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin type 1 receptor; Angiotensin converting enzyme 2; Vascular remodeling

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN[1-7]; ATENOLOL; DIPEPTIDYL CARBOXYPEPTIDASE; HYDRALAZINE; OLMESARTAN; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I (1 7); ANGIOTENSIN I (1-7); ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBOXYPEPTIDASE; IMIDAZOLE DERIVATIVE; MESSENGER RNA; PEPTIDE FRAGMENT; TETRAZOLE DERIVATIVE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA; AORTA MEDIA; ARTICLE; BODY WEIGHT; CAROTID ARTERY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART RATE; HEART WEIGHT; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; ENZYMOLOGY; GENETICS; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; THORACIC AORTA;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTA, THORACIC; ATENOLOL; CARBOXYPEPTIDASES; CAROTID ARTERIES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDRALAZINE; HYPERTENSION; IMIDAZOLES; MALE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED SHR; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; TETRAZOLES; VASODILATOR AGENTS;

EID: 23944472129     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00068.2005     Document Type: Article

References (33)

1. Albaladejo P, Carusi A, Apartian A, Lacolley P, Safar ME, and Benetos A. Effect of chronic heart rate reduction with ivabradine on carotid and aortic structure and function in normotensive and hypertensive rats. J Vase Res 40: 320-328, 2003.
2. Averill DB, Ishiyama Y, Chappell MC, and Ferrario CM. Cardiac angiotensin-(1-7) in ischemic cardiomyopathy. Circulation 108: 2141-2146, 2003.
3. Beaucage P, Yamaguchi N, Lariviere R, and Moreau P. Heterogeneity in the acute control of vascular protein synthesis in vivo. J Vasc Res 40: 123-131, 2003.
4. Benetos A, Levy BI, Lacolley P, Taillard F, Duriez M, and Safar ME. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 17: 3196-3201, 1997.
5. Bravo R, Somoza B, Ruiz-Gayo M, Gonzalez C, Ruilope LM, and Fernandez-Alfonso MS. Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats. Hypertension 37: E4-E10, 2001.
6. Brosnihan KB, Neves LA, Anton L, Joyner J, Valdes G, and Merrill DC. Enhanced expression of Ang-(1-7) during pregnancy. Brai J Med Biol Res 37: 1255-1262, 2004.
7. Chappell MC, Modrall JG, Diz DI, and Ferrario CM. Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. Contrib Nephrol 143: 77-89, 2004.
8. Collister JP and Hendel MD. The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats. J Renin Angiotensin Aldosterone Syst 4: 176-179, 2003.
9. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM. Angiotensin- converting enzyme 2 is an essential regulator of heart function. Nature 417: 822-828, 2002.
10. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, and Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9, 2000.
11. Dzau VJ. Theodore Cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37: 1047-1052, 2001.
12. Endemann DH, Touyz RM, Iglarz M, Savoia C, and Schiffrin EL. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 43: 1252-1257, 2004.
13. Ferrario CM. Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology. Curr Hypertens Rep 5: 129-134, 2003.
14. Ferrario CM, Averill DB, Brosnihan KB, Chappell MC, Iskandar SS, Dean RH, and Diz DI. Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat. Kidney Int 62: 1349-1357, 2002.
15. Ferrario CM and Chappell MC. Novel angiotensin peptides. Cell Mol Life Sci 61: 2720-2727, 2004.
16. Freeman EJ, Chisolm GM, Ferrario CM, and Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 28: 104-108, 1996.
17. Fujii K, Umemoto S, Fujii A, Yonezawa T, Sakumura T, and Matsuzaki M. Angiotensin II type 1 receptor antagonist downregulates non-muscle myosin heavy chains in spontaneously hypertensive rat aorta. Hypertension 33: 975-980, 1999.
18. Hale TM, Shoichet MJ, Bushfield TL, and Adams MA. Time course of vascular structural changes during and after short-term antihypertensive treatment. Hypertension 42: 171-176, 2003.
19. Huentelman MJ, Zubcevic J, Katovich MJ, and Raizada MK. Cloning and characterization of a secreted form of angiotensin-converting enzyme 2. Regul Pept 122: 61-67, 2004.
20. Intengan HD, Thibault G, Li JS, and Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 100: 2267-2275, 1999.
21. Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, and Ferrario CM. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43: 970-976, 2004.
22. Iyer SN, Chappell MC, Averill DB, Diz DI, and Ferrario CM. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 31: 699-705, 1998.
23. Labat C, Lacolley P, Lajemi M, de GM, Safar ME, and Benetos A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension 38: 439-443, 2001.
24. Machado RD, Ferreira MA, Belo AV, Santos RA, and Andrade SP. Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature. Regul Pept 107: 105-113, 2002.
25. Machado RD, Santos RA, and Andrade SP. Mechanisms of angiotensin-(1-7)- induced inhibition of angiogenesis. Am J Physiol Regul Integr Comp Physiol 280: R994-R1000, 2001.
26. Marchand EL, Der SS, Hamet P, and DeBlois D. Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats. Circ Res 92: 777-784, 2003.
27. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, and Niho Y. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension 32: 467-472, 1998.
28. Rice GI, Thomas DA, Grant PJ, Turner AJ, and Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383: 45-51, 2004.
29. Strawn WB, Ferrario CM, and Tallant EA. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 33: 207-211, 1999.
30. Strawn WB, Richmond RS, Tallant EA, Gallagher PE, and Ferrario CM. Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol 126: 120-126, 2004.
31. Tanaka H, Obata H, and Haneda T. Effects of regression of left ventricular hypertrophy following atenolol or bunazosin therapy on ischemic cardiac function and myocardial metabolism in spontaneously hypertensive rats. Jpn Circ J 55: 1233-1245, 1991.
32. Valdes G, Neves LAA, Anton L, Corthorn J, Chacón C, Germain AM, Merrill DC, Ferrario CM, Sarao R, Penninger J, and Brosnihan KB. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta. In press.
33. 2 receptors in isolated C57BL/6J mouse blood vessels. Am J Physiol Heart Circ Physiol 285: H2797-H2803, 2003.